Scott Mann has not acquired any additional shares
Post# of 416
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/07/2017 P 3,000 A $0.0577 24,442,189 D
Common Stock 12/07/2017 P 5,000 A $0.0576 24,447,189 D
Common Stock 12/07/2017 P 5,000 A $0.0585 24,452,189 D
Common Stock 12/07/2017 P 3,000 A $0.0595 24,455,189 D
Common Stock 12/07/2017 P 5,000 A $0.0595 24,460,189
Endonovo Therapeutics, Inc. (ENDV) Stock Research Links
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.